TickerFacts.

A business in context

DFTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-25 · 0001104659-26-112065

  2. 4 · Ownership change

    Report date 2026-09-25 · 0001104659-26-112062

  3. 4 · Ownership change

    Report date 2026-09-25 · 0001104659-26-112061

  4. 4 · Ownership change

    Report date 2026-09-25 · 0001104659-26-112060

  5. 4 · Ownership change

    Report date 2026-09-25 · 0001104659-26-112058

  6. 4 · Ownership change

    Report date 2026-09-18 · 0001193125-26-395893

  7. 4 · Ownership change

    Report date 2026-09-18 · 0001193125-26-395892

  8. 4 · Ownership change

    Report date 2026-09-14 · 0001193125-26-389892

  9. 8-K · Current report

    Report date 2026-09-14 · 0001104659-26-107275 · Items 7.01,8.01,9.01

  10. 8-K · Current report

    Report date 2026-09-08 · 0001193125-26-384403 · Items 8.01,9.01

  11. 8-K · Current report

    Report date 2026-08-12 · 0001104659-26-094528 · Items 7.01,8.01,9.01

  12. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338066

  13. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338006 · Items 2.02,9.01

  14. 8-K · Current report

    Report date 2026-06-22 · 0001104659-26-077354 · Items 1.01,8.01,9.01

  15. 8-K · Current report

    Report date 2026-06-22 · 0001104659-26-076091 · Items 7.01,8.01,9.01

  16. 8-K · Current report

    Report date 2026-06-11 · 0001193125-26-269549 · Items 5.02,5.07,9.01

  17. 8-K · Current report

    Report date 2026-05-19 · 0001193125-26-229657 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-05-12 · 0001193125-26-218251 · Items 8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211989

  20. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211929 · Items 2.02,9.01

  21. DEF 14A · Proxy statement

    Report date 2026-06-11 · 0001193125-26-182034

  22. 8-K · Current report

    Report date 2026-04-22 · 0001193125-26-170509 · Items 8.01,9.01

  23. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076742

  24. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076612 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2026-01-28 · 0001193125-26-028186 · Items 5.02

  26. 8-K · Current report

    Report date 2026-01-09 · 0001193125-26-009854 · Items 2.02,5.03,8.01,9.01

  27. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269596

  28. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269548 · Items 2.02,8.01,9.01

  29. 8-K · Current report

    Report date 2025-10-29 · 0001104659-25-104696 · Items 1.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-10-29 · 0001104659-25-103726 · Items 2.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-09-04 · 0000950170-25-112973 · Items 8.01,9.01

  32. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-100925

  33. 8-K · Current report

    Report date 2025-07-31 · 0000950170-25-100902 · Items 2.02,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-16 · 0000950170-25-086830 · Items 5.02,5.07,9.01

  35. 8-K · Current report

    Report date 2025-05-27 · 0001104659-25-052719 · Items 5.02,7.01,9.01

  36. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066387

  37. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066374 · Items 2.02,9.01

  38. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001104659-25-038010

  39. 8-K · Current report

    Report date 2025-04-18 · 0001104659-25-036841 · Items 1.01,2.03,3.02,9.01

  40. 8-K · Current report

    Report date 2025-04-15 · 0000950170-25-053953 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 6 transaction rows6SGrant / award: 11 transaction rows11AExercise / conversion: 4 transaction rows4MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

21 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-25
2026-09-29
Karlin Daniel
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares10853.036.57
2026-09-25
2026-09-29
Barrow Robert
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares31550.036.57
2026-09-25
2026-09-29
Wiley Matthew T.
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares3097.036.57
2026-09-25
2026-09-29
Sullivan Mark
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares14051.036.57
2026-09-25
2026-09-29
Roberts Brandi
10b5-1 checkbox reported
S · Sale
Disposed
Common Shares3377.036.57
2026-09-18
2026-09-18
Krebs AndreasM · Exercise / conversion
Acquired
Common Shares1629.035.52
2026-09-18
2026-09-18
Krebs AndreasM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1629.00.0
2026-09-18
2026-09-18
Vallone Carol AM · Exercise / conversion
Acquired
Common Shares1086.035.52
2026-09-18
2026-09-18
Vallone Carol AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
1086.00.0
2026-09-14
2026-09-14
Karlin DanielA · Grant / award
Acquired
Common Shares200000.00.0
2026-09-14
2026-09-14
Wiley Matthew T.A · Grant / award
Acquired
Common Shares125000.00.0
2026-09-14
2026-09-14
Sullivan MarkA · Grant / award
Acquired
Common Shares125000.00.0
2026-09-14
2026-09-14
Roberts BrandiA · Grant / award
Acquired
Common Shares125000.00.0
2026-09-14
2026-09-14
Barrow RobertA · Grant / award
Acquired
Common Shares750000.00.0
2026-09-03
2026-09-04
Barrow RobertS · Sale
Disposed
Common Shares19023.037.94
2026-09-02
2026-09-04
Barrow RobertA · Grant / award
Acquired
Common Shares40000.00.0
2026-08-12
2026-08-12
Barrow RobertA · Grant / award
Acquired
Common Shares375000.00.0
2026-08-12
2026-08-12
Karlin DanielA · Grant / award
Acquired
Common Shares100000.00.0
2026-08-12
2026-08-12
Sullivan MarkA · Grant / award
Acquired
Common Shares62500.00.0
2026-08-12
2026-08-12
Wiley Matthew T.A · Grant / award
Acquired
Common Shares62500.00.0
2026-08-12
2026-08-12
Roberts BrandiA · Grant / award
Acquired
Common Shares62500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001813814Definium Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Definium Therapeutics · alias · wikidata
  • Mind Medicine (MindMed) Inc. · former SEC name · 2020-06-08 to 2026-01-12
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗